Urology for Practice, 2010, issue 3

Editorial

Český den proti rakovině

MUDr. Vladimíra Stáhalová

Urolog. pro Praxi, 2010; 11(3): 115  

Review articles

Incontinence in old age

MUDr.Miroslava Romžová, MUDr.Marie Hurtová, MUDr.Jaroslav Pacovský, Ph.D., MUDr.Miloš Broďák, Ph.D.

Urolog. pro Praxi, 2010; 11(3): 119-123  

The urinary incontinence is the condition, when the subject is not able to voluntary control the urination. It happens to lose the urine involuntary. In the patient older than 65th year it becomes a common medical problem, more frequent than osteoporosis, cancers and cardiovascular diseases. It is not only medical, but also socio-economic problem. It seriously affects the patient’s life and its quality. New findings about pathogeneses make this problem to be treated better. Urinary incontinence in elderly is multidisciplinary proposition and a successful treatment depends on the urological cooperation with geriatrist, gynaecologist, physiotherapist,...

Current options of treatment of lower urinary tract symptoms

MUDr.Jiří Klečka, Ph.D., doc.MUDr.Milan Hora, Ph.D., MUDr.Petr Běhounek, MUDr.Viktor Eret, MUDr.Petr Stránský

Urolog. pro Praxi, 2010; 11(3): 124-130  

The article review key trials of monotherapy and combination therapy of α1-adrenergic receptor antagonists (α1 ARA), 5α reduktase inhibitors (5αIR) and antimuscarinic agents in the treatment of lower urinary tract symptoms (LUTS). We got an overview of role of different medication possibilities and combination. In the treatment od LUTS including bladder outlet obstruction (BOO) with or without over activ bladder (OAB) we can use four group of medicaion. Mentioned α1-adrenergic receptor antagonists and 5α reduktase inhibitors are widela accepted in LUTS treatment. The new drugs used in BPH resp. OAB treatment are...

Pharmacotherapy of erectile dysfunction with phosphodiesterase inhibitors

doc.MUDr.Michal Pohanka, Ph.D., prof.MUDr.RNDr.Luboslav Stárka, DrSc.

Urolog. pro Praxi, 2010; 11(3): 131-135  

Erectile dysfunction is a relatively frequent disorder substantially increasing with age. The high effective treatment of erectile dysfunction by drugs based on inhibition of phosphodiesterases type 5 (sildenafil, tadalafil, vardenafil) tempt to prescription of these drugs without careful examination. Besides personal history and physical examination it is necessary to include also laboratory data for exclusion of diseases associated with erectile dysfunction as diabetes mellitus, hyperprolactinemia or hypogonadismus. Contraindicated for treatment by inhibitors of phophodiesterases are nitrates. For patients on intensive antihypertension therapy...

Monitoring of nutritional status in uro-oncology

MUDr.Petra Holečková

Urolog. pro Praxi, 2010; 11(3): 136-139  

Nutritional support is currently receiving a little more attention; however, it still remains to be of rather marginal interest. Malnutrition, which occurs due to a number of causes in as many as 70 % of oncological patients, may complicate the course of the whole disease and worsen treatment outcomes. Nutritional screening should target patients at risk and, subsequently, appropriate nutritional intervention should be initiated. Monitoring of the nutritional status of patients should be a normal part of examination and nutritional support should become an integral part of supportive therapy in oncology.

At a glance

Nephrotic syndrome

prof.MUDr.Miroslav Merta, CSc.

Urolog. pro Praxi, 2010; 11(3): 140-143  

Nephrotic syndrome is characterised by marked (nephrotic) proteinuria associated with other clinical and laboratory findings, particularly including hypoproteinaemia, hyperlipidaemia and presence of peripheral oedemas. The crucial mechanism by which the nephrotic syndrome develops is proteinuria. Nephrotic proteinuria usually results from glomerular capillary wall damage that occurs in various types of primary and secondary glomerulonephritides. Nephrotic syndrome is particularly significant in that the oedemas and overhydration may seriously jeopardize the patient by various mechanisms, also in that the course of an advanced nephrotic syndrome...

Case report

On-lay urethroplasty using autologous tissues and heterologous collagen implant Pelvicol™. Long-term results

MUDr.Petr Kutílek, Ph.D., MUDr.Ivo Novák, Ph.D.

Urolog. pro Praxi, 2010; 11(3): 144-148  

Urethroplasties using own tissue graphts or living flaps are the most common technique in urethral stricture repair all over the world in urology practice. The resection of the urethral wall and end-to-end anastomosis of spatulated ends is used only in short deffects of bulbar urethra. Especially serious severe lost injuries or iatrogenic damage with extended spongiofibrosis of the urethral wall, where are no uneasily attainable high mentioned materials, and where is not suitable urethral resection, are all the time a problem for urethral reconstructive surgery. An alternative material for urethroplasty seems to be heterologous grafts in this...

Diagnosis and surgical treatment of renal cell carcinoma with tumor thrombus

MUDr.Eva Burešová, MUDr.Filip Čtvrlík, doc.MUDr.Vladimír Študent, Ph.D.

Urolog. pro Praxi, 2010; 11(3): 149-151  

The Czech Republic has the highest incidence of renal cell carcinoma worldwide. In 10–15 % of patients, the presence of a tumor thrombus is demonstrated at the time of diagnosis. The authors focus on the diagnosis, treatment and prognosis of locally advanced renal cell carcinoma with a tumor thrombus. Two case reports are presented showing different course of the disease. The prognosis is affected neither by the clinical condition of the patient, nor the extent of the tumor thrombus. If distant metastases are not present and the whole tumor thrombus is removed during surgery, this condition is curable.

Cystine urolithiasis - a complex solution

MUDr.Roman Král, doc.MUDr.Jan Krhut, Ph.D.

Urolog. pro Praxi, 2010; 11(3): 152-153  

This case report presents a patient with cystine nephrolithiasis. The diagnosis and treatment are described including metaphylaxis of cystine urolithiasis. It was possible, with a combined approach, to prevent the recurrence of nephrolithiasis and further deterioration of renal function.

For nurses

Endoscopy in urology

Bc.Hana Juřenová, MUDr.Břetislav Brázda

Urolog. pro Praxi, 2010; 11(3): 154-155  

The article briefly describes the development and refinement of endoscopy in urology from the very beginnings in 1806 until the present day. Individual operative techniques and examination methods, their indications and contraindications are also described. The text is accompanied by images for better understanding.

Information

Druhá zpráva o činnosti Výboru České urologické společnosti ČLS JEP

doc.MUDr.Miroslav Hanuš, CSc.

Urolog. pro Praxi, 2010; 11(3): 160-162  

Tradiční akce v „novém” prostředí - XII. ročník moravského urologického sympozia Loučná nad Desnou, hotel Dlouhé Stráně, 25.- 26. 3. 2010

Zdeňka Bartáková

Urolog. pro Praxi, 2010; 11(3): 163-164  

Good advice from practice

Voiding dysfunction in women

MUDr.Monika Hanáková

Urolog. pro Praxi, 2010; 11(3): 156-159  

At a lecture of general practitioners and urogynaecologists „On Female Incontinence“ in Brno, Czech Republic, one female GP entered the discussion and said, „… what you have been saying here, doctor, is very nice, but the reality is quite different. Most urologists don‘t even want our patients to show them their voiding diary …“ After further discussion, which showed that the female GP may have been right, and an agreement with my colleagues, I was asked to write my own „cookbook“ on how to diagnose and treat voiding dysfunctions which would prove useful, simple and effective. Although I...

Test

Autodidaktický test 3/2010

-

Urolog. pro Praxi, 2010; 11(3): 166  


Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.